Iindlela zokubona igazi kunye nomchamo ezisekelwe kumchamo ezingenaselumini ziya kubonelela abasebenzi bezempilo ngezixhobo ezichaneke kakhulu, ezingahlaseliyo zokuchonga kunye nokubeka iliso kusulelo, ukwaliwa, kunye nobuqatha bomonakalo welungu kuqhaqho kunye nezigulana ze-COVID-19.

I-Eurofins Viracor, LLC, inkokeli kuvavanyo lwezifo ezosulelayo, i-immunology, kunye ne-allergies, ibhengeze namhlanje ukuba ingene kwisivumelwano selayisenisi ekhethekileyo kunye neYunivesithi yaseCornell ukuthengisa iimvavanyo ezininzi ezaphukileyo kunye nenoveli ezijolise ekuguquleni ulawulo lwezonyango lwe-COVID- I-19 kunye nezigulana zokufakelwa zichatshazelwe kumonakalo weethishu kunye nosulelo.

I-biopsy yotyando ibalulekile ekulandeleni umonakalo we-COVID-19 emzimbeni, kodwa inkqubo inokuba buhlungu kwaye ibize kakhulu kwisigulana. Iqela leYunivesithi yaseCornell, elikhokelwa nguGqr. Iwijn De Vlaminck, unjingalwazi onxulumene naye kwiSikolo saseMeinig soBunjineli beBiomedical, lenze enye indlela ye-biopsy - inoveli, uvavanyo lwegazi olungaphazamisiyo ukulinganisa ukwenzakala kwamalungu kwi-COVID-19. Uvavanyo lusebenzisa i-DNA ejikelezayo engenaselfowuni (cfDNA) ukujonga umonakalo owenziwa yi-COVID-19 kwiiseli, izicubu kunye namalungu.

Ukongeza, i-cfDNA luhlalutyi oluguquguqukayo kakhulu lokubeka iliso kwezona ngxaki zibaluleke kakhulu zokufakelwa kweeseli ze-hematopoietic (HCT) kuphazamiseko lwegazi oluninzi kunye nomhlaza, kubandakanya neGraft-Versus-Host Disease, usulelo, ukungaphumeleli kwegrafti kunye nokuphinda kwesifo. Isivumelwano phakathi kwe-Eurofins Viracor kunye neYunivesithi yaseCornell siya kwandisa ukufikelela kwi-innovative blood-based cfDNA methylation sequencing assay yokufunyanwa kwangaphambili okanye ukuqikelelwa kweengxaki ezinkulu ezinxulumene ne-allogeneic HCT, ngaloo ndlela kuphuculwe ukunyamekelwa kwezigulane ze-stem cell transplant.

Kwesinye isicelo, i-Eurofins Viracor ijonge ukurhweba ngovavanyo lwenoveli ye-cfDNA esetyenziselwa ukuchonga ubukho bosulelo lomgudu womchamo kwizigulana zoqhaqho-fakelo lwezintso kunye nokulinganisa iqondo lomonakalo kwizintso kunye nesinyi.

Ngamandla adityanisiweyo e-Eurofins Viracor kunye neenkampani ezidibeneyo i-Transplant Genomics, Inc. kunye ne-Eurofins Donor & Testing Testing, Inc. kunye neepotfoliyo zabo zokuvavanya ukufakelwa kwezinto ezintsha, intsebenziswano yeqhinga kunye neYunivesithi yaseCornell ibonisa elinye inyathelo elibalulekileyo kwi-mission ye-Eurofins US Transplant. Iinkampani zokuxilonga ukujongana neemfuno ezingafezekiyo kulo lonke ixesha lokunyanyekelwa kwezigulane.

INTO ONOKUYITHATHA KWELI NQAKU:

I-Eurofins Viracor, LLC, inkokeli kuvavanyo lwezifo ezosulelayo, i-immunology, kunye ne-allergies, ibhengeze namhlanje ukuba ingene kwisivumelwano selayisenisi ekhethekileyo kunye neYunivesithi yaseCornell ukuthengisa iimvavanyo ezininzi ezaphukileyo kunye nenoveli ezijolise ekuguquleni ulawulo lwezonyango lwe-COVID- I-19 kunye nezigulana zokufakelwa zichatshazelwe kumonakalo weethishu kunye nosulelo.
Kwesinye isicelo, i-Eurofins Viracor ijonge ukurhweba ngovavanyo lwenoveli ye-cfDNA esetyenziselwa ukuchonga ubukho bosulelo lomgudu womchamo kwizigulana zoqhaqho-fakelo lwezintso kunye nokulinganisa iqondo lomonakalo kwizintso kunye nesinyi.
and their innovative transplant testing portfolios, the strategic collaboration with Cornell University marks another critical step in the mission of the Eurofins US Transplant Diagnostics companies to address unmet needs across the continuum of transplant patient care.